Logo image of EQX

EQUINOX GOLD CORP (EQX) Stock Fundamental Analysis

NYSEARCA:EQX - NYSE Arca - CA29446Y5020 - Common Stock - Currency: USD

6.27  -0.08 (-1.26%)

After market: 6.25 -0.02 (-0.32%)

Fundamental Rating

4

Taking everything into account, EQX scores 4 out of 10 in our fundamental rating. EQX was compared to 153 industry peers in the Metals & Mining industry. EQX has a medium profitability rating, but doesn't score so well on its financial health evaluation. EQX is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year EQX was profitable.
In the past year EQX had a positive cash flow from operations.
EQX had positive earnings in 4 of the past 5 years.
Each year in the past 5 years EQX had a positive operating cash flow.
EQX Yearly Net Income VS EBIT VS OCF VS FCFEQX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

EQX has a better Return On Assets (5.05%) than 73.38% of its industry peers.
EQX's Return On Equity of 9.99% is fine compared to the rest of the industry. EQX outperforms 77.92% of its industry peers.
With a Return On Invested Capital value of 3.12%, EQX perfoms like the industry average, outperforming 55.84% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for EQX is significantly below the industry average of 8.54%.
The last Return On Invested Capital (3.12%) for EQX is above the 3 year average (1.45%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.05%
ROE 9.99%
ROIC 3.12%
ROA(3y)0.99%
ROA(5y)3.56%
ROE(3y)2.22%
ROE(5y)5.93%
ROIC(3y)1.45%
ROIC(5y)2.87%
EQX Yearly ROA, ROE, ROICEQX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

Looking at the Profit Margin, with a value of 22.41%, EQX belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
EQX's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 15.72%, EQX is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
EQX's Operating Margin has declined in the last couple of years.
EQX has a Gross Margin of 34.64%. This is in the better half of the industry: EQX outperforms 75.32% of its industry peers.
In the last couple of years the Gross Margin of EQX has declined.
Industry RankSector Rank
OM 15.72%
PM (TTM) 22.41%
GM 34.64%
OM growth 3Y1.42%
OM growth 5Y-4.29%
PM growth 3Y-24.11%
PM growth 5YN/A
GM growth 3Y-4.28%
GM growth 5Y-4.45%
EQX Yearly Profit, Operating, Gross MarginsEQX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EQX is destroying value.
Compared to 1 year ago, EQX has more shares outstanding
EQX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for EQX is higher compared to a year ago.
EQX Yearly Shares OutstandingEQX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
EQX Yearly Total Debt VS Total AssetsEQX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 1.02, we must say that EQX is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.02, EQX is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.36 indicates that EQX is not too dependend on debt financing.
EQX has a worse Debt to Equity ratio (0.36) than 66.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z 1.02
ROIC/WACC0.32
WACC9.71%
EQX Yearly LT Debt VS Equity VS FCFEQX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.14 indicates that EQX should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.14, EQX is doing worse than 79.87% of the companies in the same industry.
EQX has a Quick Ratio of 1.14. This is a bad value and indicates that EQX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.53, EQX is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.53
EQX Yearly Current Assets VS Current LiabilitesEQX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 670.03% over the past year.
EQX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -18.64% yearly.
EQX shows a strong growth in Revenue. In the last year, the Revenue has grown by 39.14%.
The Revenue has been growing by 39.98% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)670.03%
EPS 3Y-18.64%
EPS 5YN/A
EPS Q2Q%1600%
Revenue 1Y (TTM)39.14%
Revenue growth 3Y11.84%
Revenue growth 5Y39.98%
Sales Q2Q%93.08%

3.2 Future

The Earnings Per Share is expected to grow by 21.03% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 6.25% on average over the next years.
EPS Next Y341.1%
EPS Next 2Y152.51%
EPS Next 3Y82.44%
EPS Next 5Y21.03%
Revenue Next Year33.69%
Revenue Next 2Y23.64%
Revenue Next 3Y12.23%
Revenue Next 5Y6.25%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
EQX Yearly Revenue VS EstimatesEQX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
EQX Yearly EPS VS EstimatesEQX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 1

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 29.86, which means the current valuation is very expensive for EQX.
Based on the Price/Earnings ratio, EQX is valued a bit cheaper than 65.58% of the companies in the same industry.
When comparing the Price/Earnings ratio of EQX to the average of the S&P500 Index (28.18), we can say EQX is valued inline with the index average.
EQX is valuated cheaply with a Price/Forward Earnings ratio of 6.77.
Based on the Price/Forward Earnings ratio, EQX is valued cheaply inside the industry as 92.86% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of EQX to the average of the S&P500 Index (20.81), we can say EQX is valued rather cheaply.
Industry RankSector Rank
PE 29.86
Fwd PE 6.77
EQX Price Earnings VS Forward Price EarningsEQX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

EQX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. EQX is cheaper than 68.83% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.59
EQX Per share dataEQX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

EQX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EQX has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as EQX's earnings are expected to grow with 82.44% in the coming years.
PEG (NY)0.09
PEG (5Y)N/A
EPS Next 2Y152.51%
EPS Next 3Y82.44%

0

5. Dividend

5.1 Amount

EQX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EQUINOX GOLD CORP

NYSEARCA:EQX (5/2/2025, 8:04:00 PM)

After market: 6.25 -0.02 (-0.32%)

6.27

-0.08 (-1.26%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-19 2025-02-19/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners59.41%
Inst Owner Change-0.57%
Ins Owners5.43%
Ins Owner ChangeN/A
Market Cap2.86B
Analysts80
Price Target14.28 (127.75%)
Short Float %5.77%
Short Ratio1.97
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-22.78%
Min EPS beat(2)-24.27%
Max EPS beat(2)-21.28%
EPS beat(4)2
Avg EPS beat(4)8.29%
Min EPS beat(4)-24.27%
Max EPS beat(4)44.74%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.42%
Min Revenue beat(2)-3.12%
Max Revenue beat(2)0.27%
Revenue beat(4)1
Avg Revenue beat(4)-7.42%
Min Revenue beat(4)-13.9%
Max Revenue beat(4)0.27%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)24.44%
PT rev (3m)24.44%
EPS NQ rev (1m)-0.28%
EPS NQ rev (3m)-19.86%
EPS NY rev (1m)1.19%
EPS NY rev (3m)-14.59%
Revenue NQ rev (1m)-11.84%
Revenue NQ rev (3m)-25.28%
Revenue NY rev (1m)-6.51%
Revenue NY rev (3m)-13.89%
Valuation
Industry RankSector Rank
PE 29.86
Fwd PE 6.77
P/S 1.89
P/FCF N/A
P/OCF 7.68
P/B 0.84
P/tB 0.84
EV/EBITDA 8.59
EPS(TTM)0.21
EY3.35%
EPS(NY)0.93
Fwd EY14.77%
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)0.82
OCFY13.02%
SpS3.32
BVpS7.45
TBVpS7.45
PEG (NY)0.09
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.05%
ROE 9.99%
ROCE 3.95%
ROIC 3.12%
ROICexc 3.25%
ROICexgc 3.25%
OM 15.72%
PM (TTM) 22.41%
GM 34.64%
FCFM N/A
ROA(3y)0.99%
ROA(5y)3.56%
ROE(3y)2.22%
ROE(5y)5.93%
ROIC(3y)1.45%
ROIC(5y)2.87%
ROICexc(3y)1.53%
ROICexc(5y)3.25%
ROICexgc(3y)1.53%
ROICexgc(5y)3.25%
ROCE(3y)1.84%
ROCE(5y)3.63%
ROICexcg growth 3Y-8.65%
ROICexcg growth 5Y-13.76%
ROICexc growth 3Y-8.65%
ROICexc growth 5Y-13.76%
OM growth 3Y1.42%
OM growth 5Y-4.29%
PM growth 3Y-24.11%
PM growth 5YN/A
GM growth 3Y-4.28%
GM growth 5Y-4.45%
F-Score6
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Debt/EBITDA 2.63
Cap/Depr 185.11%
Cap/Sales 27.22%
Interest Coverage 2.11
Cash Conversion 80.81%
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.53
Altman-Z 1.02
F-Score6
WACC9.71%
ROIC/WACC0.32
Cap/Depr(3y)240.75%
Cap/Depr(5y)202.16%
Cap/Sales(3y)44.6%
Cap/Sales(5y)37.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)670.03%
EPS 3Y-18.64%
EPS 5YN/A
EPS Q2Q%1600%
EPS Next Y341.1%
EPS Next 2Y152.51%
EPS Next 3Y82.44%
EPS Next 5Y21.03%
Revenue 1Y (TTM)39.14%
Revenue growth 3Y11.84%
Revenue growth 5Y39.98%
Sales Q2Q%93.08%
Revenue Next Year33.69%
Revenue Next 2Y23.64%
Revenue Next 3Y12.23%
Revenue Next 5Y6.25%
EBIT growth 1Y379.57%
EBIT growth 3Y13.43%
EBIT growth 5Y33.98%
EBIT Next Year95.85%
EBIT Next 3Y36.75%
EBIT Next 5Y28.14%
FCF growth 1Y75.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3.83%
OCF growth 3Y5.08%
OCF growth 5Y44.19%